Top News

Fed minutes: No rate cuts in 2023, inflation risk remains in focus

0

S&P Futures

3,862.00

-12.50(-0.32%)

Dow Futures

33,316.00

-100.00(-0.30%)

Nasdaq Futures

10,949.75

-49.50(-0.45%)

Russell 2000 Futures

1,778.40

-4.70(-0.26%)

Crude Oil

73.63

+0.79(+1.08%)

Gold

1,861.30

+2.30(+0.12%)

Silver

23.90

-0.06(-0.27%)

EUR/USD

1.0620

+0.0010(+0.10%)

10-Yr Bond

3.7090

-0.0840(-2.21%)

Vix

22.01

-0.89(-3.89%)

GBP/USD

1.2049

-0.0009(-0.07%)

USD/JPY

132.0550

-0.3850(-0.29%)

BTC-USD

16,841.78

+41.38(+0.25%)

CMC Crypto 200

392.81

+0.56(+0.14%)

FTSE 100

7,585.19

+31.10(+0.41%)

Nikkei 225

25,804.12

+87.26(+0.34%)

Advertisement

Longtime Bay Area biotech follows up late-stage trial data with planned $175M stock sale

Previous article

Here are the chip companies that should benefit the most from the government’s massive incentives

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Top News